These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12860680)

  • 1. Coxiella burnetii persistence in three generations of mice after application of live attenuated human M-44 vaccine against Q fever.
    Freylikhman O; Tokarevich N; Suvorov A; Vorobiova E; Totolian A
    Ann N Y Acad Sci; 2003 Jun; 990():496-9. PubMed ID: 12860680
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Coxiella burnetii by PCR in mice after administration of live M-44 vaccine.
    Mossienko EV; Tokarevich NK; Suvorov AN; Totolian AA
    Folia Microbiol (Praha); 2003; 48(1):103-4. PubMed ID: 12744085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Feasibility of Using
    Kumaresan V; Alam S; Zhang Y; Zhang G
    Front Immunol; 2021; 12():754690. PubMed ID: 34795669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
    Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
    J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
    Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
    QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
    Gregory AE; van Schaik EJ; Russell-Lodrigue KE; Fratzke AP; Samuel JE
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31501249
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy of Q fever vaccines against Coxiella burnetii experimental challenge in pregnant goats.
    Souriau A; Arricau-Bouvery N; Bodier C; Rodolakis A
    Ann N Y Acad Sci; 2003 Jun; 990():521-3. PubMed ID: 12860684
    [No Abstract]   [Full Text] [Related]  

  • 8. Promiscuous
    Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
    Front Immunol; 2019; 10():207. PubMed ID: 30828331
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens.
    Sukocheva OA; Marmion BP; Storm PA; Lockhart M; Turra M; Graves S
    QJM; 2010 Nov; 103(11):847-63. PubMed ID: 20639288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experimental study of the immunogenic and protective properties of Coxiella burnetii strain M-44 and a live enteral vaccine against Q fever].
    Mikhaĭlov VV; Vorob'ev AA; Makhlaĭ AA; Khaltaeva GG; Suvorova TA; Krasnianskiĭ VP; Iakovlev EA; Pashanin IuG; Dykanov GA; Podkuĭko VN; Lebedinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):38-42. PubMed ID: 8820676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X; Xiong X; Graves S; Stenos J; Wen B
    Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble antigens derived from
    Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
    Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxiella burnetii: host and bacterial responses to infection.
    Waag DM
    Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of inactivated Coxiella burnetii on production of proinflammatory cytokines by blood cells from healthy donors.
    Kuznetsova S; Tokarevich N; Lukacova M; Koloskov A; Freidlin I
    Ann N Y Acad Sci; 2003 Jun; 990():500-4. PubMed ID: 12860681
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the efficacy of human Q fever vaccine registered in Australia.
    Chiu CK; Durrheim DN
    N S W Public Health Bull; 2007; 18(7-8):133-6. PubMed ID: 17854543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
    QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
    Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
    Front Immunol; 2021; 12():653092. PubMed ID: 33815413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational design of a novel multi-epitope vaccine against Coxiella burnetii.
    Jaydari A; Nazifi N; Forouharmehr A
    Hum Immunol; 2020; 81(10-11):596-605. PubMed ID: 32718721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.